HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward Green Selected Research

Peptides (Polypeptides)

1/2022T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward Green Research Topics

Disease

5Neoplasms (Cancer)
01/2023 - 01/2018
5Glioma (Gliomas)
01/2022 - 01/2019
2Infections
11/2021 - 12/2018
2Pneumonia (Pneumonitis)
01/2021 - 01/2017
2Dementia (Dementias)
04/2017 - 08/2016
2Atherosclerosis
04/2017 - 08/2016
1Ovarian Teratoma
01/2022
1Tertiary Lymphoid Structures
01/2022
1Brain Neoplasms (Brain Tumor)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2022
1Neuromyelitis Optica (Devic's Disease)
01/2022
1Teratoma (Teratoid Tumor)
01/2022
1Migraine Disorders (Migraine)
10/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Hypertension (High Blood Pressure)
04/2017
1Pneumococcal Infections
01/2016
1Malaria
09/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
05/2010
1Thrombosis (Thrombus)
05/2010

Drug/Important Bio-Agent (IBA)

6VaccinesIBA
01/2021 - 01/2016
2AutoantibodiesIBA
01/2022 - 01/2022
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2021
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 01/2019
2AntigensIBA
01/2021 - 01/2019
2Protein Subunit VaccinesIBA
01/2021 - 01/2021
2Apolipoproteins E (ApoE)IBA
04/2017 - 08/2016
2florbetapirIBA
04/2017 - 08/2016
2Amyloid (Amyloid Fibrils)IBA
04/2017 - 08/2016
1PlatinumIBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1pembrolizumabIBA
01/2023
1Cisplatin (Platino)FDA LinkGeneric
01/2023
1130-nm albumin-bound paclitaxelIBA
01/2023
1Immunoglobulin A (IgA)IBA
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1anti-NMDA receptor autoantibodyIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Immunoglobulin IsotypesIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022
1Aquaporins (Water Channels)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
11/2021
1Codon (Codons)IBA
01/2021
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2021
1Amino AcidsFDA Link
01/2021
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021
1OvalbuminIBA
01/2021
1CI 22IBA
01/2021
1Tryptophan (L-Tryptophan)FDA Link
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
10/2019
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
10/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
10/2019
1Serotonin (5 Hydroxytryptamine)IBA
10/2019
1HLA-A*24:02 antigenIBA
01/2019
1HLA-A Antigens (HLA-A)IBA
01/2019
1AntioxidantsIBA
12/2018
1PolyaminesIBA
01/2018
1CholesterolIBA
04/2017
1Conjugate VaccinesIBA
01/2017
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
05/2010

Therapy/Procedure

2Therapeutics
01/2023 - 01/2022
1Drug Therapy (Chemotherapy)
01/2022
1Radiotherapy
01/2022
1Immunotherapy
01/2021
1Chemoprevention
09/2010